World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
28456
World Ranking
10977
National Ranking
5644

Overview

Fredrick M. Wigley is affiliated with Johns Hopkins University in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Rheumatology, Pulmonary and Respiratory Medicine, Epidemiology, and Cardiology and Cardiovascular Medicine.

The scientist's work covers key topics related to systemic and inflammatory diseases, cardiovascular function, and respiratory conditions. The main topics addressed in their research include:

  • Systemic Sclerosis and Related Diseases
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pulmonary Hypertension Research and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Osteoarthritis Treatment and Mechanisms
  • Cardiovascular Function and Risk Factors

Fredrick M. Wigley has contributed to academic literature published across various venues. The most frequent publication venues are:

  • Arthritis & Rheumatology
  • Circulation
  • Arthritis Care & Research
  • Clinical and Experimental Rheumatology
  • Lara D. Veeken

Their recent papers include the following titles and publication years:

  • Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline (2023) published in American Journal of Respiratory and Critical Care Medicine
  • Exercise right ventricular ejection fraction predicts right ventricular contractile reserve (2021) published in The Journal of Heart and Lung Transplantation
  • Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis (2020) published in Arthritis Care & Research
  • Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) published in Journal of Psychosomatic Research
  • Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis (2021) published in International journal of cardiac imaging

Frequent co-authors collaborating with Fredrick M. Wigley include:

  • Ami A. Shah
  • Laura K. Hummers
  • Monica Mukherjee
  • Julie J. Paik
  • Steven Hsu

Best Publications

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    John H. Stone;Gary S. Hoffman;Peter A. Merkel;Yuan I. Min

  • Review: evidence that systemic sclerosis is a vascular disease.

    Marco Matucci-Cerinic;Bashar Kahaleh;Fredrick M. Wigley

  • Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

    Christine G. Joseph;Erika Darrah;Ami A. Shah;Andrew D. Skora

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

    Micah R. Fisher;Stephen C. Mathai;Hunter C. Champion;Reda E. Girgis

  • High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

    Philip J. Clements;Daniel E. Furst;Weng Kee Wong;Maureen Mayes

  • Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

    Peter A. Merkel;Peter A. Merkel;Karen Herlyn;Richard W. Martin;Jennifer J. Anderson

  • Body Mass Index in Young Men and the Risk of Subsequent Knee and Hip Osteoarthritis

    Allan C. Gelber;Marc C. Hochberg;Lucy A. Mead;Nae Yuh Wang

  • Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

    James R. Seibold;Joseph H. Korn;Robert Simms;Phillip J. Clements

  • Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High‐dose versus low‐dose penicillamine trial

    Philip J. Clements;Eric L. Hurwitz;Weng Kee Wong;James R. Seibold

  • Foot and ankle problems in rheumatoid arthritis.

    James Michelson;Mark Easley;Fredrick M. Wigley;David Hellmann

  • Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

    Stephen C. Mathai;Laura K. Hummers;Hunter C. Champion;Fredrick M. Wigley

  • Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

    Richard J. Rodeheffer;James A. Rommer;Fredrick Wigley;Craig R. Smith

  • Deficient Smad7 expression: A putative molecular defect in scleroderma

    Chunming Dong;Shoukang Zhu;Tao Wang;Woohyun Yoon

  • Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

    B. L. Loeys;B. L. Loeys;E. E. Gerber;D. Riegert-Johnson;S. Iqbal

  • Scleroderma Autoantigens Are Uniquely Fragmented by Metal-catalyzed Oxidation Reactions: Implications for Pathogenesis

    Livia Casciola-Rosen;Fredrick Wigley;Antony Rosen

  • Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

    Paul J. DeMarco;Michael H. Weisman;James R. Seibold;Daniel E. Furst

Frequent Co-Authors

Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
John Varga
John Varga University of Michigan–Ann Arbor
Virginia D. Steen
Virginia D. Steen Georgetown University
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Antony Rosen
Antony Rosen Johns Hopkins University School of Medicine
Livia Casciola-Rosen
Livia Casciola-Rosen Johns Hopkins University School of Medicine
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Paul M. Hassoun
Paul M. Hassoun Johns Hopkins University
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor—there are several related degrees that can open doors in healthcare. Many students consider a bachelors in health administration as a foundation for roles in hospital management, policy, or healthcare consulting. This degree is ideal for those interested in the organizational aspect of medicine.

For those looking to advance further, affordable affordable mha online programs can make it easier to specialize and take on leadership responsibilities. These programs often cater to working professionals and can be completed remotely.

Clinically inclined students may choose a 1 year dnp program online to become advanced practice nurses. These programs offer flexible, accelerated study options for experienced nurses to earn a doctoral degree.

Finally, those interested in medications, therapy management, and patient safety may explore pharmacy school online. These innovative online programs are making pharmacy education more accessible than ever before.

Best Scientists Citing Fredrick M. Wigley

Trending Scientists

Recently Published Articles